A Novel Intrauterine Device for the Spatio-Temporal Release of Norethindrone Acetate as a Counter-Estrogenic Intervention in the Genitourinary Syndrome of Menopause
The genitourinary syndrome of menopause (GSM) is a widely occurring condition affecting millions of women worldwide. The current treatment of GSM involves the use of orally or vaginally administered estrogens, often with the risk of endometrial hyperplasia. The utilization of progestogens offers a m...
Saved in:
Main Authors: | Ahmed Abdelgader (Author), Mershen Govender (Author), Pradeep Kumar (Author), Yahya E. Choonara (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Norethindrone Acetate in the Medical Management of Adenomyosis
by: Siddhi Mankame, et al.
Published: (2012) -
Medical management of recurrent endometrioma with long-term norethindrone acetate
by: Muneyyirci-Delale O, et al.
Published: (2012) -
Genitourinary syndrome of menopause
by: Ranu Patni
Published: (2019) -
Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
by: Michelle S. Min, et al.
Published: (2016) -
Genitourinary menopausal syndrome: the potential of estriol
by: V.N.Prilepskaya
Published: (2018)